Cargando…
Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2
Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent. Recombinant human Apo2L/TRAIL has been under clinical trials, whereas various kinds of malignant tumors have resistance to Apo2L/TRAIL. We and others have shown that several a...
Autores principales: | Oishi, Masakatsu, Iizumi, Yosuke, Taniguchi, Tomoyuki, Goi, Wakana, Miki, Tsuneharu, Sakai, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576345/ https://www.ncbi.nlm.nih.gov/pubmed/23431365 http://dx.doi.org/10.1371/journal.pone.0055922 |
Ejemplares similares
-
The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9
por: Iizumi, Yosuke, et al.
Publicado: (2013) -
The Role of Adenine Nucleotide Translocase in the Mitochondrial Permeability Transition
por: Brustovetsky, Nickolay
Publicado: (2020) -
Adenine Nucleotide Translocase, Mitochondrial Stress, and Degenerative Cell Death
por: Liu, Yaxin, et al.
Publicado: (2013) -
Human adenine nucleotide translocases physically and functionally interact with respirasomes
por: Lu, Ya-Wen, et al.
Publicado: (2017) -
Functional Expression of Human Adenine Nucleotide Translocase 4 in Saccharomyces Cerevisiae
por: Hamazaki, Takashi, et al.
Publicado: (2011)